Non-small cell lung cancer has the greatest rate of NRG1 fusion (16) (17), but it’s also prevalent in cancers of the bladder, ovaries, pancreas, breast, and other malignancies(18). This evidence concerns the gene NRG1 and non-small cell lung carcinoma.